Search Results - "Marrogi, A"

Refine Results
  1. 1

    Increased p53 mutation load in noncancerous colon tissue from ulcerative colitis : A cancer-prone chronic inflammatory disease by HUSSAIN, S. P, AMSTAD, P, HARRIS, C. C, RAJA, K, AMBS, S, NAGASHIMA, M, BENNETT, W. P, SHIELDS, P. G, HAM, A.-J, SWENBERG, J. A, MARROGI, A. J

    Published in Cancer research (Chicago, Ill.) (01-07-2000)
    “…Ulcerative colitis (UC) is a chronic inflammatory disease that produces reactive oxygen and nitrogen species and increases the risk of colorectal cancer (CRC)…”
    Get full text
    Journal Article
  2. 2

    Treatment of mesothelioma with gene-modified PA1STK cells and ganciclovir: a phase I study by Schwarzenberger, P, Byrne, P, Gaumer, R, Norton, J, Harrison, L, Marrogi, A, Kolls, J K

    Published in Cancer gene therapy (01-12-2011)
    “…Mesothelioma is an incurable cancer of the pleura with a life expectancy of less than 1 year. On the basis of in vivo efficacy seen with the herpes simplex…”
    Get full text
    Journal Article
  3. 3

    Study of tumor infiltrating lymphocytes and transforming growth factor‐β as prognostic factors in breast carcinoma by Marrogi, Aizen J., Munshi, Anupama, Merogi, Athir J., Ohadike, Yvonne, El‐Habashi, Ahmed, Marrogi, Olga L., Freeman, Scott M.

    Published in International journal of cancer (21-10-1997)
    “…Cytokines and growth factors are powerful modulators of the immune response. Their aberrant expression either by the tumor cells or by the tumor infiltrating…”
    Get full text
    Journal Article
  4. 4
  5. 5
  6. 6

    In vivo analysis of the 'bystander effect': a cytokine cascade by Ramesh, R, Marrogi, A J, Munshi, A, Abboud, C N, Freeman, S M

    Published in Experimental hematology (01-06-1996)
    “…The "bystander effect" refers to the death of unmodified tumor cells when in contact with ganciclovir (GCV)-exposed, herpes simplex virus-thymidine kinase…”
    Get more information
    Journal Article
  7. 7

    In situ use of suicide genes for cancer therapy by Freeman, S M, Whartenby, K A, Freeman, J L, Abboud, C N, Marrogi, A J

    Published in Seminars in oncology (01-02-1996)
    “…Gene therapy has now become a standard experimental approach for treating cancers that have failed conventional therapies. As the understanding of the…”
    Get more information
    Journal Article
  8. 8

    Tumor-host interaction : Analysis of cytokines, growth factors, and tumor-infiltrating lymphocytes in ovarian carcinomas by MEROGI, A. J, MARROGI, A. J, RAMESH, R, ROBINSON, W. R, FERMIN, C. D, FREEMAN, S. M

    Published in Human pathology (01-03-1997)
    “…The host-tumor interaction may play an important role in determining tumor progress. Recent studies have shown that this interaction can be influenced by the…”
    Get full text
    Journal Article
  9. 9

    Nitric Oxide Synthase, Cyclooxygenase 2, and Vascular Endothelial Growth Factor in the Angiogenesis of Non-Small Cell Lung Carcinoma by MARROGI, Aizen J, TRAVIS, William D, LIOTTA, Lance A, HARRIS, Curtis C, WELSH, Judith A, KHAN, Mohammed A, RAHIM, Haress, TAZELAAR, Henry, PAIROLERO, Peter, TRASTEK, Victor, JETT, James, CAPORASO, Neil E

    Published in Clinical cancer research (01-12-2000)
    “…We have investigated the hypothesis that nitric oxide synthase (NOS2), cyclooxygenase-2 (COX2), and vascular endothelial growth factor (VEGF) protein levels…”
    Get full text
    Journal Article
  10. 10
  11. 11

    Enhancement of tumor killing using a combination of tumor immunization and HSV-tk suicide gene therapy by RAMESH, R, MUNSHI, A, MARROGI, A. J, FREEMAN, S. M

    Published in International journal of cancer (29-01-1999)
    “…Tumor cells genetically modified with the herpes simplex virus thymidine kinase (HSV-tk) gene in combination with ganciclovir (GCV) demonstrate a "bystander…”
    Get full text
    Journal Article
  12. 12

    The role of cytokines in mediating the bystander effect using HSV-TK xenogeneic cells by Freeman, Scott M., Ramesh, Rajagopal, Shastri, Munish, Munshi, Anupama, Jensen, Andrea K., Marrogi, Aizen J.

    Published in Cancer letters (08-06-1995)
    “…We have previously demonstrated that genetically modified syngeneic murine tumor cells (KBALB) expressing the herpes simplex virus thymidine kinase gene…”
    Get full text
    Journal Article
  13. 13

    p53 tumor suppressor gene mutations in transformed cutaneous T-cell lymphoma: A study of 12 cases by Marrogi, A. J., Khan, M. A., Vonderheid, E. C., Wood, G. S., McBurney, E.

    Published in Journal of cutaneous pathology (01-09-1999)
    “…The transformation of cutaneous T‐cell lymphoma (t‐CTCL) is an uncommon phenomenon that is associated with histopathologic changes and follows an aggressive…”
    Get full text
    Journal Article
  14. 14

    Interaction of the Hepatitis B Virus X Protein with the Crm1-dependent Nuclear Export Pathway by Forgues, Marshonna, Marrogi, Aizen J., Spillare, Elisa A., Wu, Chuan-Ging, Yang, Qin, Yoshida, Minoru, Wang, Xin Wei

    Published in The Journal of biological chemistry (22-06-2001)
    “…The leucine-rich nuclear export signal (NES) is used to shuttle large cellular proteins from the nucleus to the cytoplasm. The nuclear export receptor Crm1 is…”
    Get full text
    Journal Article
  15. 15
  16. 16

    Paradoxical Effects of Platelet-Derived Growth Factor-A Overexpression in Malignant Mesothelioma . Antiproliferative Effects In Vitro and Tumorigenic Stimulation In Vivo by Metheny-Barlow, Linda J, Flynn, Barbara, van Gijssel, Hilde E, Marrogi, Aizen, Gerwin, Brenda I

    “…Malignant mesothelioma is associated with asbestos exposure and remains resistant to all therapeutic intervention. Previous studies have suggested an enhancing…”
    Get full text
    Journal Article
  17. 17

    Pilomatrical neoplasms in children and young adults by Marrogi, A J, Wick, M R, Dehner, L P

    Published in The American journal of dermatopathology (01-04-1992)
    “…Pilomatrixoma, a neoplasm of hair germ matrix origin, is one of the most common cutaneous appendage tumors in patients 20 years of age or younger. Our review…”
    Get more information
    Journal Article
  18. 18

    The treatment of malignant mesothelioma with a gene modified cancer cell line: a phase I study by Schwarzenberger, P, Harrison, L, Weinacker, A, Marrogi, A, Byrne, P, Ramesh, R, Theodossiou, C, Gaumer, R, Summer, W, Freeman, S M, Kolls, J K

    Published in Human gene therapy (20-11-1998)
    “…Malignant mesothelioma is a tumor of the pleura for which there is no satisfactory treatment. It is almost universally fatal, regardless of the stage of the…”
    Get more information
    Journal Article
  19. 19

    Expression of costimulatory molecules: B7 and ICAM up-regulation after treatment with a suicide gene by Ramesh, R, Munshi, A, Abboud, C N, Marrogi, A J, Freeman, S M

    Published in Cancer gene therapy (01-11-1996)
    “…The herpes simplex virus thymidine kinase gene (HSV-TK) in combination with ganciclovir (GCV), is currently being used in gene therapy-based clinical trials…”
    Get more information
    Journal Article
  20. 20